Ligand Pharmaceuticals
LGND
LGND
329 hedge funds and large institutions have $3.26B invested in Ligand Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 118 increasing their positions, 125 reducing their positions, and 71 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
329
Holders Change
-33
Holders Change %
-9.12%
% of All Funds
7.13%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.09%
New
43
Increased
118
Reduced
125
Closed
71
Calls
$61.7M
Puts
$122M
Net Calls
-$60.3M
Net Calls Change
-$19.8M
Top Buyers
Top Sellers
1 |
Millennium Management
New York
|
-$67.8M |
2 |
Ameriprise
Minneapolis,
Minnesota
|
-$44.7M |
3 |
Wells Fargo
San Francisco,
California
|
-$43.5M |
4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$29.8M |
5 |
D.E. Shaw & Co
New York
|
-$19.2M |